Utilization of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Healing
Evaluation the Effect of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Epithelium Healing (Phase I and II Clinical Trial)
Sponsor study identifier
interventional
20
0 countries
N/A
Study Start
June 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2015
Actual (reported)Study Completion
November 2015
Actual (reported)For severe ocular surface diseases, such as chemical and thermal injuries, Stevens-Johnson syndrome (SJS), Band Keratopathy, Corneal Dystrophies, Refractive (PRK-LASEK), corneal surgery and others, it is important that short time treatment with minimal side effect should be considered. This study is a prospective clinical trial to use Amniotic Membrane Extract Eye Drop (AMEED) as a natural substance for acceleration of corneal healing
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2014
Date type not reportedThis date has not been verified as actual or estimated.
May 2015
Actual (reported)November 2015
Actual (reported)April 10, 2016
Actual (reported)April 21, 2016
Actual (reported)corneal defect size
Evaluation the corneal defect size (millimeter) by microscope after corneal surgery and compare the change of defect size after procedure in compare with base line (before surgery).
12 months
Eye Discharge
1 week
pain
24 hours
Patients with cornea injury who received healing Amniotic Membrane Extract Eye Drop.
Amniotic Membrane Extract use as eye drop for patients with corneal injury.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hamid Gourabi, PhD
Head of Royan Institute
Marzieh Ebrahimi, PhD
Department of Regenerative Biomedicine at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Khosro Jadidi, MD
Bina Hospital, Research & Education Center, Tehran, Iran
Fatemeh Doostmohammadi, MD
Bina Hospital, Research & Education Center, Tehran, Iran
20 participants (actual enrollment reported by the registry).
First Submitted
April 10, 2016
First Posted
April 21, 2016
Study Start
June 2014
Date type not reportedThis date has not been verified as actual or estimated.
Eyelid Taping Alone Versus Taping With Lubricant Eye Drops for Perioperative Corneal Protection
Contact the study team to confirm eligibility.
Primary Completion
May 2015
Actual (reported)Study Completion
November 2015
Actual (reported)Last Updated
April 21, 2016
Record last verified: 2016-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: